Terms: = Leukemia AND NACA, HSD48, 4666, ENSG00000196531, MGC117224, NACA1, Q13765, FKSG17, NACAP1 AND Treatment
4 results:
1. Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis.
Cao S; Tao Q; Wang J; Zhang Q; Dong Y
Medicine (Baltimore); 2023 Nov; 102(44):e34949. PubMed ID: 37933074
[TBL] [Abstract] [Full Text] [Related]
2. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
Wang J; Papanicolau-Sengos A; Chintala S; Wei L; Liu B; Hu Q; Miles KM; Conroy JM; Glenn ST; Costantini M; Magi-Galluzzi C; Signoretti S; Choueiri T; Gallucci M; Sentinelli S; Fazio VM; Poeta ML; Liu S; Morrison C; Pili R
Oncotarget; 2016 May; 7(21):29901-15. PubMed ID: 27144525
[TBL] [Abstract] [Full Text] [Related]
3. Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
Peters AC; Duan Q; Russell JA; Duggan P; Owen C; Stewart DA
Leuk Lymphoma; 2011 Nov; 52(11):2124-9. PubMed ID: 21740097
[TBL] [Abstract] [Full Text] [Related]
4. IL-18 gene expression pattern in exogenously treated AML cells.
Seo M; Park M; Yook Y; Kwon YS; Suh YJ; Kim MJ; Cho D; Park JH
BMB Rep; 2008 Jun; 41(6):461-5. PubMed ID: 18593530
[TBL] [Abstract] [Full Text] [Related]
